-
881
Image 5_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an...
منشور في 2025"…Background<p>Combining PD-1/PD-L1 inhibitors with chemotherapy (PIC) is a standard first-line treatment for advanced non-small cell lung cancer (NSCLC). The addition of bevacizumab to this regimen (PD-1/PD-L1 inhibitors+bevacizumab+chemotherapy [PIBC]) remains controversial regarding its potential to enhance antitumor efficacy in clinical practice. …"
-
882
Table 1_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an...
منشور في 2025"…Background<p>Combining PD-1/PD-L1 inhibitors with chemotherapy (PIC) is a standard first-line treatment for advanced non-small cell lung cancer (NSCLC). The addition of bevacizumab to this regimen (PD-1/PD-L1 inhibitors+bevacizumab+chemotherapy [PIBC]) remains controversial regarding its potential to enhance antitumor efficacy in clinical practice. …"
-
883
Image 6_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an...
منشور في 2025"…Background<p>Combining PD-1/PD-L1 inhibitors with chemotherapy (PIC) is a standard first-line treatment for advanced non-small cell lung cancer (NSCLC). The addition of bevacizumab to this regimen (PD-1/PD-L1 inhibitors+bevacizumab+chemotherapy [PIBC]) remains controversial regarding its potential to enhance antitumor efficacy in clinical practice. …"
-
884
Average kidney and heart weight of rats.
منشور في 2024"…To date, there are no treatments to reverse kidney fibrosis. Cannabis is an aromatic herb that is widely known for its anti-diabetic and anti-inflammatory properties. …"
-
885
The relationship between the number of publications and taxa richness in Retezat National Park.
منشور في 2025الموضوعات: -
886
Georeferenced faunistic occurrence records reported from Retezat National Park.
منشور في 2025الموضوعات: -
887
Assessment of inventory completeness in five of the most studied taxa from Retezat National Park.
منشور في 2025الموضوعات: -
888
-
889
Dynamics of the scientific publications regarding the fauna of Retezat National Park.
منشور في 2025الموضوعات: -
890
-
891
-
892
-
893
BMI distribution of study population using World Health Organisation (WHO) categories.
منشور في 2025الموضوعات: -
894
The cumulative number of species occurrences according to altitude in Retezat National Park.
منشور في 2025الموضوعات: -
895
-
896
-
897
-
898
Patient demographics by BMI missingness in the United Kingdom NJR data and Danish data.
منشور في 2025الموضوعات: -
899
-
900